QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that at its annual meeting shareholders elected Charles Orsatti to the Board of Directors. Mr. Orsatti succeeds Robert Flaherty who decided to not pursue re-election to the Board. The size of the AngioDynamics Board of Directors remains unchanged, at nine members.
